Search Results for keywords:"manufacturers"

The Environmental Protection Agency (EPA) is proposing updates to the fees charged under the Toxic Substances Control Act (TSCA) for fiscal years 2022 to 2024. This proposal aims to adjust existing fees and introduce new fee categories to ensure the fees offset a portion of the costs of the EPA's responsibilities under TSCA. New exemptions are also proposed for certain manufacturers to reduce the burden on smaller entities and those engaged in specific activities, like research and development. EPA seeks to redistribute the fees more equitably among manufacturers based on production volume, aiming to refine the fee process from previous implementations and ensure industries that contribute to chemical manufacturing support EPA's oversight and evaluation efforts.

The Federal Communications Commission (FCC) has announced the compliance date for a rule requiring manufacturers of certain video devices and services to make closed captioning settings accessible for those who are deaf or hard of hearing. The compliance date for this requirement is set for August 17, 2026. This rule aligns with the Twenty-First Century Communications and Video Accessibility Act of 2010, ensuring that video programming with captions is fully accessible, especially for devices with next-generation operating systems. The rule change was confirmed after the Office of Management and Budget (OMB) approved the related information collection requirements.

The Department of Housing and Urban Development (HUD) has announced a delay in the effective date of new construction and safety standards for manufactured homes. Initially set to take effect on March 17, 2025, the new date is now September 15, 2025. This adjustment aligns with a Presidential order for a regulatory review period and responds to manufacturers' requests for more time to adjust to new regulations. The delay aims to ensure all changes are properly reviewed and implemented for better housing safety and quality.

The Internal Revenue Service (IRS) has proposed new rules to manage an excise tax on the sale of certain designated drugs by manufacturers, producers, and importers. These regulations detail how the tax will be applied and calculated, particularly focusing on sales during specific periods defined by law. The proposed rules include definitions of terms like "manufacturer" and "sale," guidelines for identifying sales subject to the tax, and methods for calculating the tax amount. The rules aim to ensure that the tax is assessed fairly and are seeking public comments and possible requests for a hearing by March 3, 2025.